Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation von Clermont, Allen C, Murugesan, Nivetha, Edwards, Hannah J, Lee, Daniel K, Bayliss, Natasha P, Duckworth, Edward J, Pethen, Stephen J, Hampton, Sally L, Gailani, David, Feener, Edward P

Volltext

Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedem... von Davie, Rebecca L., Edwards, Hannah J., Evans, D. Michael, Hodgson, Simon T., Stocks, Michael J., Smith, Alun J., Rushbrooke, Louise J., Pethen, Stephen J., Roe, Michael B., Clark, David E., McEwan, Paul A., Hampton, Sally L.

Volltext

Sebetralstat: A Rapidly Acting Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema von Feener, Edward P., Davie, Rebecca L., Murugesan, Nivetha, Pethen, Stephen J., Hampton, Sally L., Smith, Michael D., Audhya, Paul K., Yea, Chris M.

Volltext